FDA inspection
Nang Kuang Pharmaceutical Co., Ltd.: FDA inspection ending Apr 2, 2024
FDA inspection 1236762 · Official Action Indicated (OAI) · Tai Nan Shi
Key facts
| Inspection ID | 1236762 |
|---|---|
| Firm | Nang Kuang Pharmaceutical Co., Ltd. |
| FEI number | 3004396086 |
| Address | Xinhua District, 1001 Zhongshan Rd.; Xinhua Dist. |
| City | Tai Nan Shi |
| Country | Taiwan |
| Fiscal year | 2024 |
| Inspection end date | Apr 2, 2024 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data